Michael Zdanowski
Corporate Officer/Principal presso Medeor Therapeutics, Inc.
Patrimonio netto: 1 890 $ in data 30/06/2024
Profilo
Michael Zdanowski is currently the Vice President-GMP Operations at New York Stem Cell Foundation, Inc. and the Senior VP-Biopharmaceutical Operations at Medeor Therapeutics, Inc. He was previously the Chief Technology Officer at Talaris Therapeutics, Inc. from 2020 to 2023.
He received an undergraduate degree from the University of Pennsylvania and an MBA from Columbia University School of the Arts.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
0.00% | 17/04/2023 | 147 ( 0.00% ) | 1 890 $ | 30/06/2024 |
Posizioni attive di Michael Zdanowski
| Società | Posizione | Inizio |
|---|---|---|
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| New York Stem Cell Foundation, Inc. | Corporate Officer/Principal | - |
Precedenti posizioni note di Michael Zdanowski
| Società | Posizione | Fine |
|---|---|---|
| TOURMALINE BIO, INC. | Direttore Tecnico/Scientifico/R&S | 28/04/2023 |
Formazione di Michael Zdanowski
| Columbia University School of the Arts | Masters Business Admin |
| University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |
| New York Stem Cell Foundation, Inc. | Miscellaneous |
- Borsa valori
- Insiders
- Michael Zdanowski
